These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36416595)

  • 1. Central nervous system involvement by mantle cell lymphoma.
    McLaughlin N; Wang Y; Witzig T; Villasboas J; Habermann T; Inwards D; Bennani N; Thanarajasingam G; Nowakowski G; Porrata L; Thompson C; Micallef I; Johnston P; Ansell S; Paludo J
    Leuk Lymphoma; 2023 Feb; 64(2):371-377. PubMed ID: 36416595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network.
    Cheah CY; George A; Giné E; Chiappella A; Kluin-Nelemans HC; Jurczak W; Krawczyk K; Mocikova H; Klener P; Salek D; Walewski J; Szymczyk M; Smolej L; Auer RL; Ritchie DS; Arcaini L; Williams ME; Dreyling M; Seymour JF;
    Ann Oncol; 2013 Aug; 24(8):2119-23. PubMed ID: 23616279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse.
    Rusconi C; Cheah CY; Eyre TA; Tucker D; Klener P; Giné E; Crucitti L; Muzi C; Iadecola S; Infante G; Bernard S; Auer RL; Pagani C; Duglosz-Danecka M; Mocikova H; van Meerten T; Cencini E; Marin-Niebla A; Williams ME; Angelillo P; Nicoli P; Arcari A; Morello L; Mannina D; Vitagliano O; Sartori R; Chiappella A; Sciarra R; Stefani PM; Dreyling M; Seymour JF; Visco C
    Blood; 2022 Oct; 140(17):1907-1916. PubMed ID: 35789260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system involvement in patients with mantle cell lymphoma.
    Oinonen R; Franssila K; Elonen E
    Ann Hematol; 1999 Mar; 78(3):145-9. PubMed ID: 10211757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL).
    Chihara D; Asano N; Ohmachi K; Nishikori M; Okamoto M; Sawa M; Sakai R; Okoshi Y; Tsukamoto N; Yakushijin Y; Nakamura S; Kinoshita T; Ogura M; Suzuki R
    Ann Oncol; 2015 May; 26(5):966-973. PubMed ID: 25712457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system involvement in mantle cell lymphoma.
    Ferrer A; Bosch F; Villamor N; Rozman M; Graus F; Gutiérrez G; Mercadal S; Campo E; Rozman C; López-Guillermo A; Montserrat E
    Ann Oncol; 2008 Jan; 19(1):135-41. PubMed ID: 17962207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of central nervous system relapse in mantle cell lymphoma.
    Conconi A; Franceschetti S; Lobetti-Bodoni C; Stathis A; Margiotta-Casaluci G; Ramponi A; Mazzucchelli L; Bertoni F; Ghielmini M; Gaidano G; Cavalli F; Zucca E
    Leuk Lymphoma; 2013 Sep; 54(9):1908-14. PubMed ID: 23339449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blastoid Mantle Cell Lymphoma.
    Jain P; Wang M
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):941-956. PubMed ID: 32861288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2017 Aug; 92(8):806-813. PubMed ID: 28699667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastoid Mantle Cell Lymphoma of the Palate: Report of a Rare Aggressive Entity and Review of the Literature.
    Georgaki M; Theofilou VI; Pettas E; Piperi E; Stoufi E; Panayiotidis P; Nikitakis NG
    Head Neck Pathol; 2022 Jun; 16(2):631-642. PubMed ID: 34716903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.
    Shrestha R; Bhatt VR; Guru Murthy GS; Armitage JO
    Leuk Lymphoma; 2015; 56(10):2759-67. PubMed ID: 25747972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observation as the initial management strategy in patients with mantle cell lymphoma.
    Abrisqueta P; Scott DW; Slack GW; Steidl C; Mottok A; Gascoyne RD; Connors JM; Sehn LH; Savage KJ; Gerrie AS; Villa D
    Ann Oncol; 2017 Oct; 28(10):2489-2495. PubMed ID: 28961827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNS involvement in mantle-cell lymphoma.
    Montserrat E; Bosch F; López-Guillermo A; Graus F; Terol MJ; Campo E; Rozman C
    J Clin Oncol; 1996 Mar; 14(3):941-4. PubMed ID: 8622043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later.
    Fang H; Medeiros LJ; Tang Z; Wang W; Ok CY; Patel KP; Khoury JD; Thakral B
    Ann Diagn Pathol; 2021 Feb; 50():151649. PubMed ID: 33189964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.
    Gerson JN; Handorf E; Villa D; Gerrie AS; Chapani P; Li S; Medeiros LJ; Wang M; Cohen JB; Churnetski M; Hill BT; Sawalha Y; Hernandez-Ilizaliturri FJ; Kothari S; Vose JM; Bast M; Fenske T; Rao Gari SN; Maddocks KJ; Bond D; Bachanova V; Kolla B; Chavez J; Shah B; Lansigan F; Burns T; Donovan AM; Wagner-Johnston N; Messmer M; Mehta A; Anderson JK; Reddy N; Kovach AE; Landsburg DJ; Glenn M; Inwards DJ; Ristow K; Karmali R; Kaplan JB; Caimi PF; Rajguru S; Evens A; Klein A; Umyarova E; Pulluri B; Amengual JE; Lue JK; Diefenbach C; Fisher RI; Barta SK
    Blood Adv; 2023 Dec; 7(24):7393-7401. PubMed ID: 37874912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma?
    Parrott AM; Haggiagi AM; Murty VV; Bhagat G; Alobeid B
    Hematol Oncol; 2020 Dec; 38(5):817-822. PubMed ID: 32639587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mantle cell lymphoma with central nervous system involvement: frequency and clinical features.
    Gill S; Herbert KE; Prince HM; Wolf MM; Wirth A; Ryan G; Carney DA; Ritchie DS; Davies JM; Seymour JF
    Br J Haematol; 2009 Oct; 147(1):83-8. PubMed ID: 19694718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.